Researchers in “Emerging Infectious Diseases” debunk the scenario of a global fungal pandemic as depicted in HBO’s ‘The Last of Us,’ citing slow fungal evolution and current pathologies as barriers to such an event.
Bristol Myers reinforces neuroscience deals; Iovance prices $150M public offering
Bristol Myers Squibb, a big pharma hardly synonymous with neuroscience drugs, is beefing up its work with two European biotechs in Alzheimer’s and undisclosed neurodegenerative
July 12, 2023